Journal article
P3.18.35 ARTEMIDE-Lung02: A Phase 3 Global Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for 1L Metastatic Squamous NSCLC
Authors
Lu S; Bestvina CM; Goksu SS; Goto Y; Hiltermann TJN; Mascaux C; Zhou Q; Aroldi F; Gong M; Lakhanpal M
Journal
Journal of Thoracic Oncology, Vol. 20, No. 10,
Publisher
Elsevier
Publication Date
October 1, 2025
DOI
10.1016/j.jtho.2025.09.1050
ISSN
1556-0864